SFC
REGN icon

SYM Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

SYM Financial Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Sell
574
-21
-4% -$14.3K 0.03% 216
2026
Q1 		$460K Buy
595
+13
+2% +$9.95K 0.05% 144
2025
Q4 		$449K Buy
582
+140
+32% +$95.1K 0.05% 141
2025
Q3 		$249K Buy
+442
New +$250K 0.03% 258

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SYM Financial Corp's REGN Position: Q2 2026 in Review

SYM Financial Corp reduced its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q2 2026, selling an estimated $14.3K and leaving 574 shares worth $358K. The position accounts for 0.03% of the portfolio, ranked #216.

SYM Financial Corp first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $460K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • SYM Financial Corp held 574 shares of Regeneron Pharmaceuticals worth $358K as of Q2 2026.
  • SYM Financial Corp sold 21 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $14.3K.
  • Regeneron Pharmaceuticals made up 0.03% of SYM Financial Corp's portfolio in Q2 2026, its #216 holding.
  • SYM Financial Corp first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • SYM Financial Corp's Regeneron Pharmaceuticals position peaked at $460K in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on SYM Financial Corp's 13F filing for Q2 2026, filed 4 Aug 2026.